Viewport Meta

IPhone / Mobile Compatible

Euro

Google Font API

Google Maps

WordPress

GStatic Google Static Content

WordPress 6.6

Google Maps API

Google Search Appliance

Olivier Houben

David Braga Malta

Venture Partner

Jean-Yves Nothias

Team Member

Marc Lohrmann

Managing Partner

Françoise Liners

Analyst

Guy Geldhof

Partner

Fei Tian

Alain Parthoens

Stephane Verdood

Forendo Pharma is a developer of novel drugs intended for the treatment of urological and other endocrinological diseases.

Ogeda is a privately owned clinical-stage drug discovery company.

Genkyotex develops innovative drugs to block the NOX enzymes that produce oxygen radicals.

Activaero develops breathing technologies for patients suffering from severe respiratory diseases.

Humedics specializes in instant and exact liver function measurement.

Genomic Vision is a biotechnology company developing genetic tests and research tools for the life sciences sector.

ProFibrix is a biotech company developing and commercializing products for the hemostasis and regenerative medicine markets.

Trinean is a Belgium based technology provider, bringing micro-volume molecular spectroscopy to the next level.

Venture Stage Investors with Investments in California

Venture Stage Investors with Investments in Nordic Countries

Europe, Middle East, and Africa (EMEA) Late Stage Venture Investors

Early Stage Venture Investors with Investments in Oost-Vlaanderen

Vesalius Biocapital Partners invests in companies active in human health through venture capital funds raised since 2007. They have contributed to developing 20 companies since inception.

With more than € 150 million under management in two funds. Vesalius Biocapital Partners plays the role of lead investor in the large majority of its financing rounds.
 
Their companies are based in Europe allowing easy interaction with management.

They invest in all stages of development and do not shy away from relatively early-stage projects with a sound proprietary technology and corresponding IP, unique team skills and a clear competitive edge based on solid data.

Vesalius Biocapital IV

Vesalius Biocapital III

Vesalius Biocapital II

Vesalius Biocapital I

Advertising, Business and Retail Services

Strassen

Luxembourg

Europe

Vesalius Biocapital Partners

Vesalius Biocapital to invest €95M in life science companies

Vesalius Biocapital Announces First Close of Fourth Fund Raising EUR 95 Million

United Kingdom

Germany

Global Life Science Ventures is a venture capital firm focused on investments in the life sciences sector.

Global Life Science Ventures

Panakes Partners is a venture capital firm specializing in investments in the life sciences and healthcare sectors.

Panakes Partners

Principia is a venture capital firm that invests in innovative companies in the life sciences and healthcare industries.

Principia

Maxwell Biotech Venture Fund is a venture capital fund focused on investments in the biotechnology and life sciences sectors.

Maxwell Biotech Venture Fund

Armilar Venture Partners is a venture capital firm that invests in technology-based companies, including those in the life sciences and healthcare sectors.

Armilar Venture Partners

Vesalius Biocapital is a specialized life sciences venture capital firm that invests in European and North American biotech, medtech, and diagnostics companies. The firm focuses on later-stage start-ups as well as smaller companies with a clear business model in therapeutics, medical devices, diagnostics, and e-health. Vesalius Biocapital aims to create sustainable value for its investors by leveraging its extensive expertise in the life sciences sector.

Vesalius Biocapital

news_impact_assignment_basic

key_people

merger_acquisitions

network_dossier

public_peers

news_daily_refresh

news_processing_daily_refresh

news_impact_assignment_daily

news_processing_basic

legal

legal_dossier

bundesanzeiger

events_dossier

partnerships_market_presence_dossier

partnerships_market_presence

company_dossier

network

strategic_challenges

industry_trends

strategic_challenges_dossier

industry_trends_dossier

company_summary

events

network_mapping

transactions_dossier

swot_dossier

signals

financial_statements

crunchbase_trigger

crunchbase_profile

li_profile

financials_download_nd

private_financials

swot_analysis

financial_legal_advisories

company_structure

industry_analysis

financial_analysis

funding_rounds_analysis

regulatory_analysis

competition_analysis

news_impact_assignment_advanced

news_processing_advanced

news_advanced

purchaser_profile

network_onboarding

translate_crunchbase_fundingrounds

peers

customer_profile

news_basic

valuation

news impact assignment basic	general
public peers	general	May 14, 2024 6:04 PM	166a0b9f
news daily refresh	general
news processing daily refresh	general
news impact assignment daily	general
news processing basic	general
company summary	general
signals	general
crunchbase trigger	general	Nov 25, 2024 9:06 AM	0fe94407
crunchbase profile	general	Nov 25, 2024 9:49 AM	de39169b
li profile	general
translate crunchbase fundingrounds	general	Nov 25, 2024 2:03 PM	5bee8300
peers	general
news basic	general
bundesanzeiger	filings
financials download nd	financials
private financials	financials

VESA

COM:VESALIUSBIOCAPITAL

Vesalius Biocapital